{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:27:16Z","timestamp":1787272036593,"version":"build-2736575974"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"DOI":"10.1038\/s43856-026-01660-0","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T10:36:03Z","timestamp":1779878163000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Estimating investment costs to improve hypertension care in Lagos, Nigeria"],"prefix":"10.1038","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7809-1657","authenticated-orcid":false,"given":"Charlotte M.","family":"Dieteren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8555-8596","authenticated-orcid":false,"given":"Gloria P.","family":"G\u00f3mez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atze","family":"Bellaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bolanle","family":"Banigbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martilord","family":"Ifeanyichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias F.","family":"Rinke de Wit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibironke","family":"Dada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuella","family":"Zamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3550-6939","authenticated-orcid":false,"given":"Judith M.","family":"van Andel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"1660_CR1","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","volume":"396","author":"GBD 2019 Risk Factors Collaborators","year":"2020","unstructured":"GBD 2019 Risk Factors Collaborators Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Lond. Engl. 396, 1223\u20131249 (2020).","journal-title":"Lancet Lond. Engl."},{"key":"1660_CR2","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth, G. A. et al. Global burden of cardiovascular diseases and risk factors, 1990\u20132019. J. Am. Coll. Cardiol. 76, 2982\u20133021 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1660_CR3","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/S0140-6736(19)30955-9","volume":"394","author":"P Geldsetzer","year":"2019","unstructured":"Geldsetzer, P. et al. The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1\u00b71 million adults. Lancet Lond. Engl. 394, 652\u2013662 (2019).","journal-title":"Lancet Lond. Engl."},{"key":"1660_CR4","doi-asserted-by":"publisher","first-page":"1008335","DOI":"10.3389\/fcvm.2022.1008335","volume":"9","author":"NW Minja","year":"2022","unstructured":"Minja, N. W. et al. Cardiovascular diseases in Africa in the twenty-first century: gaps and priorities going forward. Front. Cardiovasc. Med. 9, 1008335 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"1660_CR5","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1111\/jch.14220","volume":"23","author":"D Adeloye","year":"2021","unstructured":"Adeloye, D. et al. Prevalence, awareness, treatment, and control of hypertension in Nigeria in 1995 and 2020: a systematic analysis of current evidence. J. Clin. Hypertens. 23, 963\u2013977 (2021).","journal-title":"J. Clin. Hypertens."},{"key":"1660_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.5334\/gh.848","volume":"15","author":"AN Odili","year":"2020","unstructured":"Odili, A. N. et al. Prevalence, awareness, treatment and control of hypertension in Nigeria: data from a Nationwide survey 2017. Glob. Heart 15, 47 (2020).","journal-title":"Glob. Heart"},{"key":"1660_CR7","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s11606-015-3566-1","volume":"31","author":"V Naanyu","year":"2016","unstructured":"Naanyu, V. et al. Barriers influencing linkage to hypertension care in Kenya: qualitative analysis from the LARK hypertension study. J. Gen. Intern. Med. 31, 304\u2013314 (2016).","journal-title":"J. Gen. Intern. Med."},{"key":"1660_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-021-06433-0","volume":"21","author":"G Ng","year":"2021","unstructured":"Ng, G. et al. Coping with access barriers to non-communicable disease medicines: qualitative patient interviews in eight counties in Kenya. BMC Health Serv. Res 21, 417 (2021).","journal-title":"BMC Health Serv. Res"},{"key":"1660_CR9","doi-asserted-by":"publisher","unstructured":"Gafane-Matemane, L. F. et al. Hypertension in sub-Saharan Africa: the current profile, recent advances, gaps, and priorities. J. Hum. Hypertens. 1\u201316 https:\/\/doi.org\/10.1038\/s41371-024-00913-6 (2024).","DOI":"10.1038\/s41371-024-00913-6"},{"key":"1660_CR10","doi-asserted-by":"publisher","first-page":"e074274","DOI":"10.1136\/bmjopen-2023-074274","volume":"13","author":"P Otieno","year":"2023","unstructured":"Otieno, P. et al. Perceived health system facilitators and barriers to integrated management of hypertension and type 2 diabetes in Kenya: a qualitative study. BMJ Open 13, e074274 (2023).","journal-title":"BMJ Open"},{"key":"1660_CR11","doi-asserted-by":"publisher","first-page":"e008731","DOI":"10.1161\/JAHA.118.008731","volume":"7","author":"EB Kirkland","year":"2018","unstructured":"Kirkland, E. B. et al. Trends in healthcare expenditures among US adults with hypertension: national estimates. J. Am. Heart Assoc. 7, e008731 (2018). 2003\u20132014.","journal-title":"J. Am. Heart Assoc."},{"key":"1660_CR12","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1016\/S0140-6736(12)62000-5","volume":"381","author":"D Balabanova","year":"2013","unstructured":"Balabanova, D. et al. Good health at low cost 25 years on: lessons for the future of health systems strengthening.  Lancet 381, 2118\u20132133 (2013).","journal-title":"Lancet"},{"key":"1660_CR13","doi-asserted-by":"publisher","first-page":"e002213","DOI":"10.1136\/bmjgh-2019-002213","volume":"5","author":"D Kostova","year":"2020","unstructured":"Kostova, D. et al. The cost-effectiveness of hypertension management in low-income and middle-income countries: a review. BMJ Glob. Health 5, e002213 (2020).","journal-title":"BMJ Glob. Health"},{"key":"1660_CR14","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1161\/CIRCRESAHA.121.318083","volume":"128","author":"RM Carey","year":"2021","unstructured":"Carey, R. M., Wright, J. T., Taler, S. J. & Whelton, P. K. Guideline-driven management of hypertension: an evidence-based update. Circ. Res. 128, 827\u2013846 (2021).","journal-title":"Circ. Res."},{"key":"1660_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.5334\/gh.952","volume":"16","author":"H Das","year":"2021","unstructured":"Das, H. et al. Cost-effectiveness of improved hypertension management in India through increased treatment coverage and adherence: a mathematical modeling study. Glob. Heart 16, 37 (2021).","journal-title":"Glob. Heart"},{"key":"1660_CR16","first-page":"1199","volume":"80","author":"KB Bryant","year":"2023","unstructured":"Bryant, K. B. et al. Effectiveness and cost-effectiveness of team-based care for hypertension: a meta-analysis and simulation study. Hypertens. Dallas Tex. 1979 80, 1199\u20131208 (2023).","journal-title":"Hypertens. Dallas Tex. 1979"},{"key":"1660_CR17","doi-asserted-by":"publisher","first-page":"e033631","DOI":"10.1161\/JAHA.123.033631","volume":"13","author":"J Chay","year":"2024","unstructured":"Chay, J. et al. Cost-effectiveness of a multicomponent primary care intervention for hypertension. J. Am. Heart Assoc. 13, e033631 (2024).","journal-title":"J. Am. Heart Assoc."},{"key":"1660_CR18","doi-asserted-by":"publisher","first-page":"e0273439","DOI":"10.1371\/journal.pone.0273439","volume":"17","author":"M Davari","year":"2022","unstructured":"Davari, M., Sorato, M. M., Kebriaeezadeh, A. & Sarrafzadegan, N. Cost-effectiveness of hypertension therapy based on 2020 International Society of Hypertension guidelines in Ethiopia from a societal perspective. PLoS One 17, e0273439 (2022).","journal-title":"PLoS One"},{"key":"1660_CR19","doi-asserted-by":"publisher","DOI":"10.26633\/RPSP.2022.140","volume":"46","author":"AE Moran","year":"2022","unstructured":"Moran, A. E. et al. Building the health-economic case for scaling up the WHO-HEARTS hypertension control package in low- and middle-income countries. Rev. Panam. Salud P\u00fabl. 46, e140 (2022).","journal-title":"Rev. Panam. Salud P\u00fabl."},{"key":"1660_CR20","unstructured":"Banigbe, B. F. An assessment of health facility service readiness and the quality of care provided to patients with diabetes and hypertension in Lagos State, Nigeria. https:\/\/open.bu.edu\/handle\/2144\/45084 (2022)."},{"key":"1660_CR21","unstructured":"World Bank. GDP per capita (current US$) \u2013 Nigeria. World Development Indicators. https:\/\/data.worldbank.org\/country\/nigeria (2024)."},{"key":"1660_CR22","unstructured":"African Development Bank Group. Africa\u2019s macroeconomic performance and outlook. (2025)."},{"key":"1660_CR23","unstructured":"Lagos Population 2026. World Population Review https:\/\/worldpopulationreview.com\/cities\/nigeria\/lagos (2026)."},{"key":"1660_CR24","unstructured":"World Health Organization. UHC service coverage index. Data https:\/\/data.who.int\/indicators\/i\/3805B1E\/9A706FD (2024)."},{"key":"1660_CR25","first-page":"11","volume":"162","author":"CA Onoka","year":"2016","unstructured":"Onoka, C. A., Hanson, K. & Mills, A. Growth of health maintenance organisations in Nigeria and the potential for a role in promoting universal coverage efforts. Soc. Sci. Med. 1982 162, 11\u201320 (2016).","journal-title":"Soc. Sci. Med. 1982"},{"key":"1660_CR26","doi-asserted-by":"crossref","unstructured":"Guirguis-Blake, J. M. et al. Screening for Hypertension in Adults: An Updated Systematic Evidence Review for the U.S. Preventive Services Task Force (Agency for Healthcare Research and Quality (US), Rockville (MD), 2021).","DOI":"10.1001\/jama.2020.21669"},{"key":"1660_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-021-06146-4","volume":"21","author":"LN Aminde","year":"2021","unstructured":"Aminde, L. N., Dzudie, A., Mapoure, Y. N., Tantchou, J. C. & Veerman, J. L. Estimation and determinants of direct medical costs of ischaemic heart disease, stroke and hypertensive heart disease: evidence from two major hospitals in Cameroon. BMC Health Serv. Res. 21, 140 (2021).","journal-title":"BMC Health Serv. Res."},{"key":"1660_CR28","first-page":"1","volume":"ume 7","author":"O Iseko","year":"2018","unstructured":"Iseko, O., Adeniji, F., Osungbade, K. & Iseko, I. Analysis of direct medical costs of acute stroke among patients in a tertiary hospital in Ibadan, South-West, Nigeria. Afr. J. Health Econ. ume 7, 1\u20139 (2018).","journal-title":"Afr. J. Health Econ."},{"key":"1660_CR29","doi-asserted-by":"crossref","unstructured":"Nyassinde, J. et al. Hospital direct cost of stroke in sub-Saharan Africa: the case of Senegal. J. Neurol. Sci. 429, 119949 (2021).","DOI":"10.1016\/j.jns.2021.119348"},{"key":"1660_CR30","doi-asserted-by":"publisher","first-page":"e0157925","DOI":"10.1371\/journal.pone.0157925","volume":"11","author":"NTA Rosendaal","year":"2016","unstructured":"Rosendaal, N. T. A. et al. Costs and cost-effectiveness of hypertension screening and treatment in adults with hypertension in rural Nigeria in the context of a health insurance program. PLoS One 11, e0157925 (2016).","journal-title":"PLoS One"},{"key":"1660_CR31","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/eurjpc\/zwac285","volume":"30","author":"Y Li","year":"2023","unstructured":"Li, Y., Cao, G.-Y., Jing, W.-Z., Liu, J. & Liu, M. Global trends and regional differences in incidence and mortality of cardiovascular disease, 1990-2019: findings from 2019 global burden of disease study. Eur. J. Prev. Cardiol. 30, 276\u2013286 (2023).","journal-title":"Eur. J. Prev. Cardiol."},{"key":"1660_CR32","doi-asserted-by":"publisher","unstructured":"Ojo, A. E., Ojji, D. B., Grobbee, D. E., Huffman, M. D. & Peters, S. A. E. The burden of cardiovascular disease attributable to hypertension in Nigeria: a modelling study using summary-level data Global Heart. https:\/\/doi.org\/10.5334\/gh.1332 (2024).","DOI":"10.5334\/gh.1332"},{"key":"1660_CR33","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/S2213-8587(17)30015-3","volume":"5","author":"P Ueda","year":"2017","unstructured":"Ueda, P. et al. Laboratory-based and office-based risk scores and charts to predict 10-year risk of cardiovascular disease in 182 countries: a pooled analysis of prospective cohorts and health surveys. Lancet Diab. Endocrinol. 5, 196\u2013213 (2017).","journal-title":"Lancet Diab. Endocrinol."},{"key":"1660_CR34","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/S0140-6736(21)00590-0","volume":"397","author":"K Rahimi","year":"2021","unstructured":"Rahimi, K. et al. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis.  Lancet 397, 1625\u20131636 (2021).","journal-title":"Lancet"},{"key":"1660_CR35","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2147\/DMSO.S55221","volume":"7","author":"RA Adebayo","year":"2014","unstructured":"Adebayo, R. A. et al. Prevalence and pattern of overweight and obesity in three rural communities in southwest Nigeria. Diab. Metab. Syndr. Obes. Targets Ther. 7, 153\u2013158 (2014).","journal-title":"Diab. Metab. Syndr. Obes. Targets Ther."},{"key":"1660_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-14-455","volume":"14","author":"SN Akarolo-Anthony","year":"2014","unstructured":"Akarolo-Anthony, S. N., Willett, W. C., Spiegelman, D. & Adebamowo, C. A. Obesity epidemic has emerged among Nigerians. BMC Public Health 14, 455 (2014).","journal-title":"BMC Public Health"},{"key":"1660_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-019-8010-8","volume":"19","author":"D Adeloye","year":"2019","unstructured":"Adeloye, D. et al. Current prevalence pattern of tobacco smoking in Nigeria: a systematic review and meta-analysis. BMC Public Health 19, 1719 (2019).","journal-title":"BMC Public Health"},{"key":"1660_CR38","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1016\/S0140-6736(18)31694-5","volume":"392","author":"KJ Foreman","year":"2018","unstructured":"Foreman, K. J. et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016\u201340 for 195 countries and territories.  Lancet 392, 2052\u20132090 (2018).","journal-title":"Lancet"},{"key":"1660_CR39","unstructured":"World Bank Open Data. World Bank Open Data https:\/\/data.worldbank.org."},{"key":"1660_CR40","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/s41582-021-00542-4","volume":"17","author":"RO Akinyemi","year":"2021","unstructured":"Akinyemi, R. O. et al. Stroke in Africa: profile, progress, prospects and priorities. Nat. Rev. Neurol. 17, 634\u2013656 (2021).","journal-title":"Nat. Rev. Neurol."},{"key":"1660_CR41","doi-asserted-by":"publisher","first-page":"e019477","DOI":"10.1136\/bmjgh-2025-019477","volume":"11","author":"M Ifeanyichi","year":"2026","unstructured":"Ifeanyichi, M. et al. Optimising care for uncomplicated type 2 diabetes mellitus in Lagos, Nigeria: cost and benefit estimates using real-world data. BMJ Glob. Health 11, e019477 (2026).","journal-title":"BMJ Glob. Health"},{"key":"1660_CR42","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1478-7547-11-2","volume":"11","author":"OI Ekwunife","year":"2013","unstructured":"Ekwunife, O. I., Okafor, C. E., Ezenduka, C. C. & Udeogaranya, P. O. Cost-utility analysis of antihypertensive medications in Nigeria: a decision analysis. Cost. Eff. Resour. Alloc. CE 11, 2 (2013).","journal-title":"Cost. Eff. Resour. Alloc. CE"},{"key":"1660_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-016-1409-3","volume":"16","author":"FN Ngalesoni","year":"2016","unstructured":"Ngalesoni, F. N., Ruhago, G. M., Mori, A. T., Robberstad, B. & Norheim, O. F. Cost-effectiveness of medical primary prevention strategies to reduce absolute risk of cardiovascular disease in Tanzania: a Markov modelling study. BMC Health Serv. Res. 16, 185 (2016).","journal-title":"BMC Health Serv. Res."},{"key":"1660_CR44","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1478-7547-5-3","volume":"5","author":"B Robberstad","year":"2007","unstructured":"Robberstad, B., Hemed, Y. & Norheim, O. F. Cost-effectiveness of medical interventions to prevent cardiovascular disease in a sub-Saharan African country\u2014the case of Tanzania. Cost. Eff. Resour. Alloc. 5, 3 (2007).","journal-title":"Cost. Eff. Resour. Alloc."},{"key":"1660_CR45","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12962-016-0059-y","volume":"14","author":"MT Tolla","year":"2016","unstructured":"Tolla, M. T. et al. Prevention and treatment of cardiovascular disease in Ethiopia: a cost-effectiveness analysis. Cost. Eff. Resour. Alloc. CE 14, 10 (2016).","journal-title":"Cost. Eff. Resour. Alloc. CE"},{"key":"1660_CR46","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jval.2019.09.2749","volume":"23","author":"M Gad","year":"2020","unstructured":"Gad, M. et al. Supporting the development of evidence-informed policy options: an economic evaluation of hypertension management in Ghana. Value Health 23, 171\u2013179 (2020).","journal-title":"Value Health"},{"key":"1660_CR47","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1161\/CIRCULATIONAHA.105.535922","volume":"112","author":"TA Gaziano","year":"2005","unstructured":"Gaziano, T. A., Steyn, K., Cohen, D. J., Weinstein, M. C. & Opie, L. H. Cost-effectiveness analysis of hypertension guidelines in South Africa: absolute risk versus blood pressure level. Circulation 112, 3569\u20133576 (2005).","journal-title":"Circulation"},{"key":"1660_CR48","doi-asserted-by":"publisher","first-page":"e000964","DOI":"10.1136\/bmjgh-2018-000964","volume":"3","author":"J Ochalek","year":"2018","unstructured":"Ochalek, J., Lomas, J. & Claxton, K. Estimating health opportunity costs in low-income and middle-income countries: a novel approach and evidence from cross-country data. BMJ Glob. Health 3, e000964 (2018).","journal-title":"BMJ Glob. Health"},{"key":"1660_CR49","doi-asserted-by":"publisher","first-page":"e833","DOI":"10.1016\/S2214-109X(23)00162-6","volume":"11","author":"A Pichon-Riviere","year":"2023","unstructured":"Pichon-Riviere, A., Drummond, M., Palacios, A., Garcia-Marti, S. & Augustovski, F. Determining the efficiency path to universal health coverage: cost-effectiveness thresholds for 174 countries based on growth in life expectancy and health expenditures. Lancet Glob. Health 11, e833\u2013e842 (2023).","journal-title":"Lancet Glob. Health"},{"key":"1660_CR50","unstructured":"World Health Organization. Noncommunicable diseases. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/noncommunicable-diseases (2025)."},{"key":"1660_CR51","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1093\/eurheartj\/ehr003","volume":"32","author":"LM Ruilope","year":"2011","unstructured":"Ruilope, L. M. & Bakris, G. L. Renal function and target organ damage in hypertension. Eur. Heart J. 32, 1599\u20131604 (2011).","journal-title":"Eur. Heart J."},{"key":"1660_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-10-71","volume":"10","author":"II Ulasi","year":"2010","unstructured":"Ulasi, I. I., Ijoma, C. K. & Onodugo, O. D. A community-based study of hypertension and cardio-metabolic syndrome in semi-urban and rural communities in Nigeria. BMC Health Serv. Res. 10, 71 (2010).","journal-title":"BMC Health Serv. Res."},{"key":"1660_CR53","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/jch.12496","volume":"17","author":"OS Ogah","year":"2015","unstructured":"Ogah, O. S., Sliwa, K., Akinyemi, J. O., Falase, A. O. & Stewart, S. Hypertensive heart failure in Nigerian Africans: insights from the Abeokuta heart failure registry. J. Clin. Hypertens. 17, 263\u2013272 (2015).","journal-title":"J. Clin. Hypertens."},{"key":"1660_CR54","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e607","volume":"344","author":"M Orteg\u00f3n","year":"2012","unstructured":"Orteg\u00f3n, M., Lim, S., Chisholm, D. & Mendis, S. Cost effectiveness of strategies to combat cardiovascular disease, diabetes, and tobacco use in sub-Saharan Africa and South East Asia: mathematical modelling study.  BMJ 344, e607 (2012).","journal-title":"BMJ"},{"key":"1660_CR55","doi-asserted-by":"publisher","first-page":"103655","DOI":"10.1016\/j.euroecorev.2021.103655","volume":"132","author":"P Dubois","year":"2021","unstructured":"Dubois, P., Lefouili, Y. & Straub, S. Pooled procurement of drugs in low and middle income countries. Eur. Econ. Rev. 132, 103655 (2021).","journal-title":"Eur. Econ. Rev."},{"key":"1660_CR56","doi-asserted-by":"publisher","first-page":"e715","DOI":"10.1016\/S2214-109X(22)00005-5","volume":"10","author":"K Hanson","year":"2022","unstructured":"Hanson, K. et al. The Lancet Global Health Commission on financing primary health care: putting people at the centre. Lancet Glob. Health 10, e715\u2013e772 (2022).","journal-title":"Lancet Glob. Health"},{"key":"1660_CR57","unstructured":"World Health Organization. Recommendations on digital interventions for health system strengthening. https:\/\/www.who.int\/publications\/i\/item\/9789241550505 (2019)."},{"key":"1660_CR58","unstructured":"World Health Organization. Boosting digital health can help prevent millions of deaths from noncommunicable diseases. https:\/\/www.who.int\/news\/item\/23-09-2024-boosting-digital-health-can-help-prevent-millions-of-deaths-from-noncommunicable-diseases (2024)."},{"key":"1660_CR59","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/tmi.13842","volume":"28","author":"RE Sanya","year":"2023","unstructured":"Sanya, R. E. et al. Effectiveness of self-financing patient-led support groups in the management of hypertension and diabetes in low- and middle-income countries: systematic review. Trop. Med. Int. Health 28, 80\u201389 (2023).","journal-title":"Trop. Med. Int. Health"},{"key":"1660_CR60","doi-asserted-by":"publisher","first-page":"e073652","DOI":"10.1136\/bmjopen-2023-073652","volume":"13","author":"P Otieno","year":"2023","unstructured":"Otieno, P. et al. Effectiveness of integrated chronic care models for cardiometabolic multimorbidity in sub-Saharan Africa: a systematic review and meta-analysis. BMJ Open 13, e073652 (2023).","journal-title":"BMJ Open"},{"key":"1660_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s41256-024-00368-9","volume":"9","author":"O Ogungbe","year":"2024","unstructured":"Ogungbe, O., Abasilim, C., Huffman, M. D. & Ojji, D. Hypertension Treatment in Nigeria Program Team. Improving hypertension control in Nigeria: early policy implications from the Hypertension Treatment in Nigeria program. Glob. Health Res. Policy 9, 26 (2024).","journal-title":"Glob. Health Res. Policy"},{"key":"1660_CR62","doi-asserted-by":"publisher","first-page":"e058840","DOI":"10.1136\/bmjopen-2021-058840","volume":"12","author":"K Stokes","year":"2022","unstructured":"Stokes, K., Oronti, B., Cappuccio, F. P. & Pecchia, L. Use of technology to prevent, detect, manage and control hypertension in sub-Saharan Africa: a systematic review. BMJ Open 12, e058840 (2022).","journal-title":"BMJ Open"},{"key":"1660_CR63","doi-asserted-by":"publisher","first-page":"e010704","DOI":"10.1136\/bmjgh-2022-010704","volume":"8","author":"R Baltussen","year":"2023","unstructured":"Baltussen, R. et al. Decision-making processes for essential packages of health services: experience from six countries. BMJ Glob. Health 8, e010704 (2023).","journal-title":"BMJ Glob. Health"}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01660-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01660-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01660-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:04:08Z","timestamp":1787270648000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01660-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1660"],"URL":"https:\/\/doi.org\/10.1038\/s43856-026-01660-0","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"11 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Compting interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"448"}}